lgbtDB

(Q30832)

Statements

title
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia. (English)
1 reference
stated in
PubMed
abstract
Gender-affirming hormone therapy (GAHT) is used by many transgender and gender-diverse adults to align physical characteristics with their gender identity, reduce gender incongruence and improve psychological functioning. (English)
series ordinal
1
copyright statement
© 2024 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. (English)
publisher
John Wiley & Sons Australia
on behalf of
Royal Australasian College of Physicians
date copyrighted
2024
rights holder
Q30824
Ada Cheung
1 reference
stated in
PubMed
This narrative review provides an overview of the initiation and monitoring of GAHT in an Australian context. (English)
series ordinal
2
copyright statement
© 2024 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. (English)
publisher
John Wiley & Sons Australia
on behalf of
Royal Australasian College of Physicians
date copyrighted
2024
rights holder
Q30824
Ada Cheung
1 reference
stated in
PubMed
Trans individuals treated with testosterone typically receive standard testosterone doses and formulations recommended for cisgender men, whereas those receiving estradiol GAHT are typically treated with estradiol in combination with an anti-androgen in those without orchidectomy. (English)
series ordinal
3
copyright statement
© 2024 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. (English)
publisher
John Wiley & Sons Australia
on behalf of
Royal Australasian College of Physicians
date copyrighted
2024
rights holder
Q30824
Ada Cheung
1 reference
stated in
PubMed
Proactive monitoring and mitigation of cardiovascular risk factors is pertinent in all transgender and gender-diverse adults and bone health is an important consideration in those using estradiol GAHT. (English)
series ordinal
4
copyright statement
© 2024 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. (English)
publisher
John Wiley & Sons Australia
on behalf of
Royal Australasian College of Physicians
date copyrighted
2024
rights holder
Q30824
Ada Cheung
1 reference
stated in
PubMed
date published
September 2024
1 reference
stated in
PubMed
date issued
September 2024
1 reference
stated in
PubMed
volume
54
1 reference
stated in
PubMed
issue
9
1 reference
stated in
PubMed
page(s)
1450-1457
1 reference
stated in
PubMed
page start
1450
1 reference
stated in
PubMed
page end
1457
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q30832&oldid=185790"